Alwyn Capital

Alwyn Capital invests in early‑stage biotechnology companies developing plant‑based proteins, cultivated meat, fermentation, recombinant technologies and non‑animal materials, including organ‑on‑chip models. They aim to reduce dependence on animals, addressing climate and human health challenges.